You are here: Industry Insights > Connect Biopharma

News List

Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member firstwordpharma
August 24, 2021
Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the "Company") today announced Mr. Jiang Bian has joined the Company as General Counsel & Chief Compliance Officer, effective August 20, 2021.
Connect Biopharma Announces Appointment of Karen J. Wilson and Dr. Kleanthis G. Xanthopoulos to Board of Directors prnasia
November 13, 2020
Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, announced the appointment of Karen J. Wilson ...
Connect Biopharma Reports Positive Topline Data from Moderate-to-severe Atopic Dermatitis (AD) Phase 1b Study of CBP-201 prnasia
January 09, 2020
AD, a common condition that can have multiple negative effects on the lives of affected individuals, is a chronic inflammatory disorder characterized by eczematous skin lesions, itch, localized pain, and sleep disturbances. It is also a common condition,
Connect Biopharma Reports Positive Data from Atopic Dermatitis Study americanpharmaceuticalreview
January 09, 2020
Connect Biopharma announced positive topline data from the Phase 1b study of its novel IL-4Rα antibody, CBP-201, in patients with moderate-to-severe atopic dermatitis (AD).